Sydney, Australia, 10 April 2025: Imugene Limited (ASX: IMU), a clinical-stage immuno oncology company, is pleased to announce that it will hold a webinar for shareholders, investors and other interested parties to discuss the latest updates on the business while answering frequently asked questions submitted by shareholders. The webinar will be hosted by Executive Chairman Paul Hopper, and he will be joined by CEO & Managing Director Leslie Chong and Chief Operating Officer Bradley Glover. The webinar will be held at 11:00am AEST on Wednesday 16 April 2025. Shareholders, investors and interested parties can register to attend the webinar at the following link: https://us02web.zoom.us/webinar/register/WN_EH_SAZ5HRhSqakP_yDKHeA Shareholders are encouraged to submit questions for the webinar in advance via email at: [email protected] A recording will be available at the above link shortly after the conclusion of the live session, and the replay will also be available via the Company’s website and social media channels. For more information please contact: Leslie Chong Managing Director and Chief Executive Officer [email protected] General Investor Enquiries [email protected] Media Enquiries Matt Wright [email protected]
IMU Price at posting:
2.4¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)